Lipomics Technologies Overview
- Founded
-
2000
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Lipomics Technologies General Information
Description
Provider of metabolite profiling, biomarker discovery and metabolism consultation services. The company develops diagnostic tests for important measures of metabolic function. It provides metabolic assessments for drug research, clinical diagnostics and personalized medicine. It uses its technologies to discover new diagnostic biomarkers, improve drug discovery, develop companion diagnostics.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Diagnostic Equipment
Medical Supplies
Acquirer
Primary Office
- 3410 Industrial Boulevard
- Suite 103
- West Sacramento, CA 95691
- United States
+1 (916) 000-0000
Lipomics Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 01-Aug-2012 | Completed | Generating Revenue | |||
| 5. Merger/Acquisition | 18-Sep-2008 | 00.000 | Completed | Generating Revenue | ||
| 4. Convertible Debt | 09-Apr-2008 | 00000 | 00.000 | Completed | Generating Revenue | |
| 3. Later Stage VC (Series D) | 24-May-2007 | 00.000 | 00.000 | Completed | Generating Revenue | |
| 2. Later Stage VC | 23-Oct-2006 | $585K | $2.76M | Completed | Generating Revenue | |
| 1. Later Stage VC (Series C) | 01-Dec-2003 | $2.17M | $2.17M | Completed | Startup |
Lipomics Technologies Patents
Lipomics Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2005284830-A1 | Metabolite markers for weight management | Inactive | 13-Sep-2004 | 00000000000 | |
| CA-2579809-A1 | Metabolite markers for weight management | Inactive | 13-Sep-2004 | 00000000000 | |
| EP-1789806-A2 | Metabolite markers for weight management | Inactive | 13-Sep-2004 | 00000000000 | |
| US-20060088860-A1 | Metabolite markers for weight management | Inactive | 13-Sep-2004 | 00000000000 | 00 |
| US-20090221081-A1 | Metabolite markers for weight management | Inactive | 13-Sep-2004 | G01N33/6893 |
Lipomics Technologies Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Anula Jayasuriya Ph.D | Self | Board Member | 000 0000 |
| Michael Miille Ph.D | Self | Board Member | 000 0000 |
Lipomics Technologies Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Draper Fisher Jurvetson Management | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Tethys Bioscience | Corporation | Majority | 000 0000 | 000000 0 | |
| Vencore Capital | Venture Capital | Minority | 000 0000 | 000000 0 |